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Abstract 
Background: An increasing numbers of studies show low diversity of the gut microbiome in 
those with chronic diseases such as obesity, inflammatory bowel disease, and allergy.  
Manipulation of the microbiota may promote health. However, the adult microbiota is stable 
and may be difficult to change.  Understanding the fixed and modifiable factors which 
determine colonisation in early life may provide strategies for acquisition of a health-
promoting microbiome.   
Summary: Not enough is known about the long-term effects of established determinants of 
gut colonisation, including delivery mode, perinatal antibiotics and infant diet.  It has been 
suggested that weaning onto solid diet containing non-digestible carbohydrates and cessation 
of breastfeeding are key stages in the colonisation process.  In addition, the microbiome of 
the placenta, amniotic fluid and breast milk, alongside vaginal and faecal bacteria, may aid 
the transfer of maternal bacteria to the infant. However, methodological issues such as 
contamination during collection and/or analysis should be considered.   
Key messages: The factors determining early colonisation are becoming more evident. 
However, longitudinal studies of microbiome maturation into late childhood and adulthood 
are required. The nutrition and health status of the mother before, during and after birth may 
be major factors in the early colonisation of the infant.  
  
Introduction 
Knowledge of the bacteria in the human gut has increased substantially since the microbiome, 
the collective genome of the gut microbiota, has been elucidated and elaborated in different 
populations [1,2].  There have been several studies implicating the gut microbiota in 
inflammatory bowel disease [3], irritable bowel syndrome [4], obesity [5], allergy [6], auto 
immune disease and many other potential conditions including brain disorders [7].  The 
number and types of bacteria in the gut are important but their metabolic activity is also key 
to their impact in the body.  Similar metabolic activities may be provided by different groups 
of bacteria and the exact species responsible for a particular function may not be as important 
as the metabolic capability of the consortium.  The metabolic profile of the microbiota may 
be influenced by diet as well as other environmental and host factors.  Understanding the 
fixed and modifiable factors which determine which bacteria are present and the resultant 
metabolic profile is key to determining the role of the bacteria in promoting health or causing 
disease and should indicate possible interventions and treatments for combatting a range of 
conditions. 
The gut microbiota is thought to be quite stable in adulthood [8] although more studies are 
needed to really establish this.  There are many barriers to new colonisation by bacteria in the 
adult human including gastric acid, bile acids, pancreatic enzymes and most importantly the 
colonisation resistance of the host microbiome.  These factors make it very difficult for 
bacteria from the diet or environment to establish long term in the human intestine.   This is 
well demonstrated by the transient residence of probiotic bacteria in the human gut despite 
ingestion in large numbers.   These barriers to colonisation are reduced in the new-born when 
gut function including acid secretion, pancreatic function and the gut associated immune 
system are immature. They may be reduced in the adult by antibiotics, disease, and gut 
washout for example.  Faecal transplantation is being increasingly explored to deal with 
dysbiosis in different conditions such as persistent Clostridia difficile infection [9].  However, 
it is more likely that early intervention in the first year of life will be successful in changing 
the gut microbiome than strategies employed in adulthood.  The initial colonisation and 
establishment of bacteria in the gastrointestinal tract in early life is likely to be a major factor 
in determining the adult gut microbiome.  Thus, early events in the first year of life may 
programme the microbiome and its activities into adulthood and if so have major influence on 
metabolism and disease risk. 
Factors affecting early colonisation 
There have been many studies which considered early colonisation of the infant gut [10-12].  
As techniques have improved and gene sequencing has made more detailed analysis of the 
microbiota and microbiome possible, the factors which influence colonisation have been 
come more clearly established.  The infant gut, mostly sterile at birth, is exposed to bacteria 
in the birth canal and from the mother’s faeces during delivery.  Infants born by caesarean 
section do not have this exposure and nearly all studies, regardless of technique used, report 
significant differences in the faecal bacteria of infants born vaginally or by caesarean section 
[10-13].  The nature and extent of these differences vary between studies and may be related 
to population variation and local obstetric practices. It is not clear how long these differences 
in the microbiota persist as not many longitudinal studies have been carried out.  In 
Gronlund’s study [13] it was suggested they lasted at least a month.  The INFABIO study 
reported significant differences persisted 4 weeks after the start of weaning [10] but the 
impact of caesarean birth diminished over the first year and only few metabolic differences 
were observed at one year (Edwards et al., unpublished data).  Another major factor 
determining early colonisation is the use of perinatal antibiotics.  These may be given to the 
infant after birth but also to the mother around the time of birth and during lactation.  There 
are initially major impacts of these antibiotics on the gut bacteria but the effects which were 
still seen at 6 weeks [10] were not maintained in the longer term.  Country of birth was a 
major influence on the colonisation of the infant gut which persisted beyond other factors.  In 
the INFABIO study of infants from five European countries (Sweden, UK, Germany, Italy 
and Spain) followed from birth to one year, there was a North-South gradient of the bacterial 
colonisation in the gut with more bifidobacteria dominated microbiota in the North and more 
bacteroides predominant in the South.  These differences were still evident 4 weeks after the 
start of weaning [10] and may persist longer as geographical differences are reported in 
several studies [1,2].  Host genetics may be a key factor in early colonisation but while some 
studies have shown greater similarity in the microbiota of identical twins [14] than fraternal 
twins and siblings others have not [15].    
 
 
 
Transfer from mother before and during birth, 
During birth the infant should be exposed to the mother’s vaginal bacteria and the microbiota 
from the faeces of the mother.  This could provide the infant with bacteria the mother has 
acquired which have ‘worked’ in her environment and therefore may be of benefit to the 
infant.  It has been long believed that the infant is born from a sterile environment in utero 
and the first bacteria are encountered in the birth canal.  However, there is increasing 
evidence that bacteria can be present in placenta, cord blood and amniotic fluid [16,17].  The 
presence of bacteria in utero may also occur via vaginal transfer and contamination either 
during sample collection or during analysis must be ruled out [18].  If this placental transfer 
is established then its importance in overall gut bacterial colonisation and the factors 
controlling the process need to be explored. 
Transfer from mother during breast feeding 
It is well established that breastfed infants have more bifidobacteria in their microbiota than 
formula fed infants and this may be due to a variety of factors in human milk including 
oligosaccharides, lactoferrin, and low iron levels.  However, a clear breast milk microbiome 
has been established in several studies [19].  Cabrera-Rubio et al measured the human milk 
microbiome at three different time points and related the composition to BMI, weight gain 
and mode of delivery.   They found the milk of obese mothers had a less diverse microbiome 
than normal weight mothers and there was a major difference in the breastmilk bacteria of 
mothers with normal delivery and those undergoing elective caesarean but not emergency 
caesarean [19].   In a Chinese study of the microbiota in breastmilk of mothers measured 
from birth to 2 months of age, the milk was expressed with or without aseptic cleaning of the 
breast before collection.  There was much greater diversity of the breastmilk microbiome of 
those who did not clean the breast suggesting a significant contribution from the skin of the 
breast and they found no effect of stage of lactation or delivery mode [20].   
Another source of bacterial transfer may be from oral contact.  One mode of transfer is 
parental behaviour around pacifier use.  Some parents may suck the pacifier before giving to 
the child and pass more bacteria to the infant.  Hesselmar et al [21] found a distinct pattern of 
colonisation in infants at 4 months of age between those whose mothers cleaned the pacifier 
by sucking and those that did not. 
 
Impact of weaning diet. 
There is considerable impact of the post weaning infant diet on the microbiota of the infant 
with diversity increasing as the child is weaned [10].   Development of fermentation capacity 
for a range on non-digestible carbohydrates increases during weaning with polysaccharides 
fermentation developing more slowly than oligosaccharides [22, 23].  Some bacterial 
enzymes and products such as β glucuronidase and butyrate do not increase substantially until 
later in the first year of life and cessation of breastfeeding, rather than introduction of solids, 
has been reported to be a major influence on development of the adult style microbiota [24]. 
Thus, diet during this period may influence maturation of the microbiota.   
Inclusion of prebiotics and probiotics in the infant diet has been shown to increase the 
bifidobacterial and lactobacilli populations but it is not clear if this persists long after the 
prebiotics and probiotics have been discontinued.   However, there have been longer term 
impacts reported on eczema after mothers and high risk infants were given probiotics [25]. 
There is a lack of human dietary and probiotic intervention studies over the longer term to 
determine if the differences seen in individuals with very different habitual diets can be 
related to early colonisation events, long-term modifiable dietary patterns or to a whole range 
of host factors. 
How can we study the gut microbiome and its activities? 
Although study of bacterial colonisation using microbiome analysis, including 
transcriptomics, can help unravel the factors influencing early colonisation and later health, it 
is very difficult to access events and microbiota populations in the proximal colon where 
most bacterial metabolism of dietary constituents, host secretions and cellular remnants 
occurs.  Key differences in the production of bioactive molecules, such as short chain fatty 
acids, which modulate host metabolism and function may be missed.  The bacteria can live in 
different niches and biofilms and may be associated with the mucosa, mucin layer or food 
remnants.  The vast majority of studies have concentrated on faecal samples to analyse the 
gut microbiome and its metabolites, with a limited number of studies using gut mucosal 
samples and colonic contents.  Studying the metabolism of the bacteria in the proximal colon 
in vivo is particularly difficult without invasive techniques which may disrupt normal 
metabolism, using intubation or capsules.  Metabolomic studies may be useful but are still 
difficult to interpret.  Stable isotope studies have great potential to trace bacterial metabolism, 
but very few studies have been carried out so far. 
Early microbiome and later disease  
The role of early bacterial colonisation in the fine tuning of immune function has been 
explored since the initial proposal of the hygiene hypothesis which noted that allergy was 
higher in populations with smaller families, more urban environment and less rigorous use of 
vaccines and antibiotics.  Altered immune function and development of allergy have been 
clearly linked to early colonisation [26, 27].  In addition, the association between the gut 
microbiome and obesity in adults has led to studies exploring the development of the 
microbiome and obesity in children.  Despite evidence suggesting that a gut microbiome with 
lower numbers of bifidobacteria in infancy is related to later obesity [5, 28], children with 
hyperphagic disorders [29], including Prader Willi syndrome, who developed obesity had 
more similar gut bacterial activity to normal obese children than those with the same 
condition but who had not become obese indicating that the bacterial differences may have 
been caused by the obesity and not vice versa.  
Conclusion 
The gut microbiome has been related to a range of different acute and chronic diseases which 
stimulates consideration of strategies to modify/optimise the bacterial profile and activities.  
However, the adult microbiome is believed to be remarkably stable and has its own 
colonisation resistance which means encroachment by novel species including pathogens and 
probiotics remains transient.   Changing initial colonisation during birth and infancy by 
controlling for factors such as perinatal antibiotics, mode of delivery and infant diet may be 
more successful in the long term but this still needs to be fully established in prospective 
long-term studies. The impact of maternal diet and health status as well as placental and 
breastmilk microbiomes also need to be considered.  
 
References 
1. Suzuki TA, Worobey M: Geographical variation of human gut microbial composition.   
Biol Lett 10; 2013:1037. 
2. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini 
S, Pieraccini G, Lionetti P: Impact of diet in shaping gut microbiota revealed by a 
comparative study in children from Europe and rural Africa.  PNAS 2010; 107: 
14691-96.  
3. Quince C, Ijaz UZ, Loman N, Eren AM, Saulnier D, Russell J, Haig SJ, Calus ST, 
Quick J, Barclay A, Bertz M, Blaut M, Hansen R, McGrogan P, Russell RK, Edwards 
CA, Gerasimidis K: Extensive modulation of the fecal metagenome in children with 
Crohn's disease during exclusive enteral nutrition. Am J Gastroenterol 2015; 110: 
1718-29.  
4. Codling C, O'Mahony L, Shanahan F, Quigley EM, Marchesi JR: A molecular 
analysis of fecal and mucosal bacterial communities in Irritable bowel syndrome.  Dig 
Dis Sci 2010 ; 55; 392-7. 
5. Khan MJ, Gerasimidis K, Edwards CA, Shaikh MG: Role of gut microbiota in the 
aetiology of obesity: proposed mechanisms and review of the literature. J Obes 2016; 
2016:7353642. 
6. Lynch SV, Boushey HA: The microbiome and development of allergic disease. Curr 
Opin Allergy Clin Immunol 2016; 16: 165-71.  
7. Wang Y, Kasper LH  The role of microbiome in central nervous system disorders.  
Brain Behavior and Immunity 2014 doi.org/10.1016/j.bbi.2013.12.015 
8. Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, 
Clemente JC, Knight R, Heath AC, Leibel RL, Rosenbaum M, Gordon JI: The long-
term stability of the human gut microbiota. Science. 2013; 341(6141):1237439. doi: 
10.1126/science.1237439 
9. Chapman BC, Moore HB, Overbey DM, Morton AP, Harnke B, Gerich ME, Vogel 
JD: Fecal microbiota transplant in patients with Clostridium difficile infection: A 
systematic review. J Trauma Acute Care Surg. 2016; 81:756-64. doi: 
10.1097/TA.0000000000001195. 
10. Fallani M, Amarri S, Uusijarvi A, Adam R, Khanna S, Aguilera M, Gil A, Vieites JM, 
Norin E, Young D, Scott JA, Doré J, Edwards CA; INFABIO team: Determinants of 
the human infant intestinal microbiota after the introduction of first complementary 
foods in infant samples from five European centres. Microbiology 2011; 157:1385-92. 
11. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, 
Stobbering EE:  Factors influencing the composition of the intestinal microbiota in 
early infancy.  Pediatrics 2006; 118: 511- 521. 
12. Valles Y, Gosalbes MJ, deVries LE, Abellan JJ, Francin MP: Metagenomics and 
development of the gut microbiota in infants  Clin Microbiol Infection 2012; 18: 21-6. 
13. Grönlund MM, Lehtonen OP, Eerola E, Kero P: Fecal microflora in healthy infants 
born by different methods of delivery: permanent changes in intestinal flora after 
cesarean delivery. J Pediatr Gastroenterol Nutr. 1999; 28:19-25. 
14. Stewart JA, Chadwick VS, Murray A: Investigations into the influence of host 
genetics on the predominant eubacteria in the faecal microflora of children. J Med 
Microbiol. 2005; 54:1239-42. 
15. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, 
Magris M, Hidalgo G, Baldassano RN, Anokhin AP, Heath AC, Warner B, Reeder J, 
Kuczynski J, Caporaso JG, Lozupone CA, Lauber C, Clemente JC, Knights D, Knight 
R, Gordon JI: Human gut microbiome viewed across age and geography. Nature. 
2012; 486(7402):222-7. doi: 10.1038/nature11053. 
16. Jiménez E, Fernández L, Marín ML, Martín R, Odriozola JM, Nueno-Palop C, 
Narbad A, Olivares M, Xaus J, Rodríguez JM: Isolation of commensal bacteria from 
umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol 
2005; 51: 270-4. 
17. Collado MC, Rautava S, Aakko J Isolauri E, Salminen S: Human gut colonisation 
may be initiated in utero by distinct microbial communities in the placenta and 
amniotic fluid. Sci Rep. 2016 Mar 22; 6:23129. doi: 10.1038/srep23129. 
18. Lauder AP, Roche AM, Sherrill-Mix S, Bailey A, Laughlin AL, Bittinger K, Leite R, 
Elovitz MA, Parry S, Bushman FD: Comparison of placenta samples with 
contamination controls does not provide evidence for a distinct placenta microbiota. 
Microbiome 2016; 4: 29. doi: 10.1186/s40168-016-0172-3. 
19. Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A: The 
human milk microbiome changes over lactation and is shaped by maternal weight and 
mode of delivery.  Am J Clin Nutr 2012; 96, 544-51. 
20. Sakwinska O, Moine D, Delley M, Combremont S, Rezzonico E, Descombes P, 
Vinyes-Pares G, Zhang Y, Wang P, Thakkar SK: Microbiota in breast milk of Chinese 
lactating mothers. PLoS One 2016;11:e0160856. doi:10.1371/journal.pone.0160856.  
eCollection 2016. 
21. Hesselmar B, Sjoberg F, Saalman R, Aberg N, Adlerberth I, Wold AE: Pacifier 
cleaning practices and risk of allergy development.  Pediatrics 2013; 131: e1829- 37. 
22. Parrett AM, Edwards CA, Lokerse E: Colonic fermentation capacity in vitro: 
development during weaning in breast-fed infants is slower for complex 
carbohydrates than for sugars. Am J Clin Nutr 1997; 65: 927-33. 
23. Scheiwiller J, Arrigoni E, Brouns F, Amado R: Human fecal microbiota develops the 
ability to degrade type 3 resistant starch during weaning.  J Pediatr Gastroenterol Nutr 
2016; 43: 584-91. 
24. Bäckhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, Li Y, Xia Y, 
Xie H, Zhong H, Khan MT, Zhang J, Li J, Xiao L, Al-Aama J, Zhang D, Lee YS, 
Kotowska D, Colding C, Tremaroli V, Yin Y, Bergman S, Xu X, Madsen L, 
Kristiansen K, Dahlgren J, Wang J: Dynamics and stabilization of the human gut 
microbiome during the first year of life. Cell Host Microbe 2015; 17: 690-703. doi: 
10.1016/j.chom.2015.04.004. 
25. Kalliomäki M, Salminen S, Poussa T, Isolauri E: Probiotics during the first 7 years of 
life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J 
Allergy Clin Immunol 2007; 119:1019-21. 
26. Johansson MA, Saghafian-Hedengren S, Haileselassie Y, Roos S, Troye-Blomberg M, 
Nilsson C, Sverremark-Ekström E: Early life gut bacteria associate with IL-4-, IL-10- 
and IFN-γ production at two years of age. PLoS One  2012, e49315 doi 
10.1371/jpournal.pone.0049315.  
27. Sjogren YM, Jenmalm MC, Bottcvher MF, Bjorksten B, Sverremark-Ekstrom E: 
Altered early infant gut microbiota in children developing allergy up to 5 years of age.  
Clin Exp Allergy 2009; 39: 518-526. 
28. Kalliomaki M, Collado MC, Salminen S, Isolauri E: Early differences in fecal 
microbiota composition in children may predict overweight. Am J Clin Nutr 2008; 
87:534-8. 
29. Khan MJ, Quince C, S V, Ijaz UZ, Loman N, Calus ST, Quick J, Haig SJ, Shaikh 
MG, Edwards CA, Gerasimidis K: A detailed analysis of the gut microbial diversity 
and metabolic activity in children with obesity of different aetiology and lean 
controls. Proc Nutr Soc 2015; 74: E75. 
Conflicts of interest 
Professor Edwards is chair of the working group on Early bacterial colonisation and potential 
implications later in life for ILSI Europe and has taken part in a workshop for Unilever. 
